Chief Financial Officer
Stanislas MALMEZAT is Chief Financial Officer of Domain Therapeutics. He joined the company in 2018 to structure and develop the financial department as well as to assist the CEO in fundraising and strategic development. Prior to joining Domain Therapeutics he developed extensive operational background during more than 6 years as CFO at Rarecells Diagnostics and later at CleveXel Pharma. Before that, he acquired a solid experience in corporate finance working in a French Venture Capital fund specialized in Biotechnology then as consultant in the Corporate Restructuring & Transaction Services department of Ernst & Young and later, at Duff & Phelps Paris in Merger and Acquisition operations. Stanislas started his career in the pharmaceutical industry as Product Manager at Johnson & Johnson. He has a PhD in pharmacy and is a graduate from the ESSEC Business School, Paris, France.